Pharmafile Logo
Pharmafocus logo
Advanced Search

Roche

Showing 15 posts of 710 posts found.

Avastin picture

Avastin now available in UK for ovarian cancer

January 17, 2012
Sales and Marketing Cancer, Cancer Drugs Fund, NICE, Roche, avastin

Roche’s Avastin is now available as a treatment for women with ovarian cancer in the UK. Avastin (bevacizumab) can now …

News
p0024

Avastin gains EU licence for ovarian cancer

January 3, 2012
Sales and Marketing Roche, avastin, ovarian

Roche’s Avastin has been granted a new European licence to treat ovarian cancer, which could help offset falling sales of …

News
Roche picture

EMA panel gives positive opinion for Roche’s Zelboraf

December 16, 2011
Sales and Marketing EMA, Roche, Zelboraf

The EMA’s advisory committee is recommending the approval of Roche’s skin cancer drug Zelboraf.  The European regulator’s Committee for Medicinal …

News
Victrelis picture

Merck and Roche begin combination hep C trial

December 16, 2011
Research and Development, Sales and Marketing Copegus, Merck, Pegasys, Roche, Victrelis

Merck and Roche have started clinical trials to investigate combinations of their hepatitis C drugs. The first trial is designed …

News

Roche makes changes in its corporate executive committee

December 15, 2011
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Roche

Roche has made two new appointments in its corporate executive committee. Sophie Kornowski-Bonnet, currently general manager of Roche in France, …

Appointment
RoActemra

NICE gives partial recommendation for RoActemra

December 14, 2011
Sales and Marketing RoActemra, Roche

Roche’s patient access scheme has persuaded NICE to recommend RoActemra in childhood arthritis under certain circumstances. In its final guidance …

News
Roche picture

Roche’s new breast cancer drug succeeds in late-stage trial

December 9, 2011
Research and Development, Sales and Marketing Roche, breast cancer, pertuzumab

Roche’s next generation breast cancer drug pertuzumab has helped patients to live over six months longer. CLEOPATRA, the first randomised …

News

Roche unveils Zurich translational partnership

December 7, 2011
Research and Development Roche, Zurich, academic alliance, translational research

Roche has unveiled a new research collaboration with academic researchers and leading clinical centres in Switzerland. The Basel-based pharma company …

News

Roche’s Lung cancer test approved for Europe

December 5, 2011
Research and Development, Sales and Marketing Roche, Tarceva, lung cancer

A new test which should help to better target treatment of patients with non-small cell lung cancer (NSCLC) has received …

News
Roche picture

Roche inks $490 million deal with PTC Therapeutics

November 30, 2011
Research and Development, Sales and Marketing PTC Therapeutics, Roche

Roche has signed a $490 million deal with specialist biotech firm PTC Therapeutics. Roche is paying PTC $30 million upfront …

News
Roche picture

Roche opens $271m formulations centre

November 29, 2011
Manufacturing and Production Roche, manufacturing

Roche has officially opened a 250 million Swiss franc ($271m) R&D centre in Switzerland that will be used to develop …

News
Eylea picture

Lucentis rival gains US approval

November 22, 2011
Research and Development, Sales and Marketing Bayer, Eylea, Lucentis, Novartis, Regeneron, Roche

A rival to Roche and Novartis’ drug Lucentis has received FDA approval for a common form of eye disease. Eylea …

News
Avastin picture

FDA pulls Roche’s Avastin for breast cancer

November 21, 2011
Research and Development, Sales and Marketing FDA, Roche, avastin

The FDA has pulled Avastin’s breast cancer licence in the US after the drug failed to prove its safety and …

News
Roche pic

Roche’s skin cancer drug receives FDA priority review

November 9, 2011
Research and Development, Sales and Marketing Roche, vismodegib

Roche’s skin cancer pill vismodegib will receive a priority review from the FDA which could see it approved within six …

News

Abbott spin-off could attract mega merger

October 21, 2011
Research and Development, Sales and Marketing Abbott, Bayer, Humira, Merck, Roche

Abbott’s new spin-off pharma firm could attract a lot of attention from big pharma looking to sure up their portfolios. …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025